An industry for healthy lives

Vaccines Europe represents all the major vaccine companies operating in Europe which undertake 79% of their global production and more than 50% of their global research projects in the region.

News & press releases

European Immunisation Week 2014 “Immunisation for life” is here

2014 04 22 Written by Vaccines Europe

This year’s European Immunisation Week celebrates 40 years since the introduction of the WHO Expanded Programme on Immunisation (EPI) by the World Health Assembly in 1974. Since its creation, the EPI programme has significantly contributed to guiding the establishment of standardized vaccination schedules for major vaccine-preventable diseases in the Member States, such as TB, tetanus, diphtheria, pertussis, polio, and measles. Read more…

“BE BOLD, BE BRAVE, AND BE CREATIVE” Commissioner Tonio Borg call to develop innovative and sustainable approaches to prevention and disease management at first EU Chronic Disease Summit, 03-04 April 2014

2014 04 16 Written by Vaccines Europe

Vaccines Europe was pleased to be invited to attend and play an active role in occasion of the first EU Summit on Chronic Diseases organised and hosted by the European Commission’s Directorate-General for Health & Consumers last 3-4 April 2014.

The Summit brought together a set of high-level stakeholders representatives of governments, public health authorities, research organisations, insurers, industry, patients, and the NGO community to join voices in discussing the increasingly pressing burden posed by chronic diseases in the EU, which is set to rise with the projected demographic change and growing number of elderly. Read more…

EU-funded FLURESP project provides evidence of cost-effectiveness of vaccination strategies in influenza pandemic scenarios

2014 03 31 Written by Vaccines Europe

Vaccines Europe was pleased to attend the Final Conference of the DG SANCO-funded FLURESP project hosted last 28 March 2014 in Luxembourg, chaired by Dr. Ariel Beresniak from the French University of Paris-Descartes.

 Funded under the 2nd EU Health Programme 2008-2013, FLURESP aimed to assess the performance and socio-economic impact of difference response strategies for human influenza pandemics in Europe in order to improve European preparedness planning and support decision-making in the framework of national pandemic preparedness plans. Effective prioritisation requires relevant information to refrain decision makers from premature commitment of resources as well as a willingness to use tools and processes that lead to informed and responsible decisions. Read more…

Page 1 of 912345...Last »